AQ
AQST
Methodology breakdown computing — it will appear here on its own.
Aquestive Therapeutics Inc (AQST) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for AQST — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 49.70 | NEUTRAL |
| Stochastic %K (14) | 24.32 | NEUTRAL |
| CCI (20) | -7.59 | NEUTRAL |
| Williams %R (14) | -75.68 | NEUTRAL |
| MACD (12,26,9) | -0.05 | SELL |
| ROC (10) | -7.27 | SELL |
| Momentum (10) | -0.38 | SELL |
| EMA (10) | 5.06 | SELL |
| SMA (10) | 5.16 | SELL |
| EMA (20) | 4.91 | SELL |
| SMA (20) | 4.93 | SELL |
| EMA (30) | 4.76 | BUY |
| SMA (30) | 4.62 | BUY |
| EMA (50) | 4.57 | BUY |
| SMA (50) | 4.37 | BUY |
| EMA (100) | 4.45 | BUY |
| SMA (100) | 4.29 | BUY |
| EMA (200) | 4.70 | BUY |
| SMA (200) | 4.45 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
About Aquestive Therapeutics Inc
Healthcare · Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy; KYNMOBI, a sublingual film formulation of apomorphine; and AZSTARYS, an fda-approved, once-daily product for the treatment of ADHD in patients age 6 years or older. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.
Background via Yahoo Finance — informational, not part of the verdict.
🟢 STRONG BUY SETUP
Strong confluence across multiple layers — outperforming the market by 21.1%, RSI in healthy zone, Wall Street broadly bullish. High conviction entry. Use `!plan AQST [entry] [stop] [target]` to size the position properly.
Scores: 4 bullish / 1 bearish
Average — needs more confirmation before sizing up
SMC — Top Down
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 62 |
| ⏰ 4H | BULLISH | 43 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | RANGING | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Insider Activity (90d)
CLUSTER SELL 0 buys · 3 sells
Recent: Barber Daniel sold 635574 sh @ $4.16 (2026-06-15); Barber Daniel sold 630943 sh @ $4.03 (2026-07-15); Barber Daniel sold 610574 sh @ $4.00 (2026-07-16)
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.